Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-3,782,339
Closed -$7.53M 14
2025
Q3
$7.53M Sell
3,782,339
-43,613
-1% -$89.2K 0.23% 14
2025
Q2
$7.46M Hold
3,825,952
0.21% 13
2025
Q1
$5.82M Hold
3,825,952
0.2% 13
2024
Q4
$7.61M Buy
3,825,952
+3,561,952
+1,349% +$8.45M 0.27% 14
2024
Q3
$586K Hold
264,000
0.02% 18
2024
Q2
$808K Hold
264,000
0.03% 19
2024
Q1
$739K Hold
264,000
0.02% 22
2023
Q4
$510K Hold
264,000
0.01% 26
2023
Q3
$404K Hold
264,000
0.01% 29
2023
Q2
$391K Hold
264,000
0.01% 30
2023
Q1
$383K Hold
264,000
﹤0.01% 31
2022
Q4
$350K Hold
264,000
﹤0.01% 33
2022
Q3
$338K Hold
264,000
﹤0.01% 39
2022
Q2
$545K Hold
264,000
0.01% 38
2022
Q1
$924K Hold
264,000
0.01% 34
2021
Q4
$2.13M Hold
264,000
0.02% 31
2021
Q3
$3.79M Hold
264,000
0.02% 23
2021
Q2
$3.58M Hold
264,000
0.03% 17
2021
Q1
$4.74M Buy
+264,000
New +$6.01M 0.06% 12

Other funds holding ADAG

General Atlantic's ADAG Position: Q4 2025 in Review

General Atlantic sold out of Adagene (ADAG) in Q4 2025, closing a stake of 3,782,339 shares — an estimated $7.53M sold.

General Atlantic first reported a position in ADAG in Q1 2021 and held it in 19 quarters. The position peaked at $7.61M in Q4 2024. 17 funds tracked by Wall St. Rank hold ADAG as of Q4 2025.

  • General Atlantic reported no remaining Adagene position as of Q4 2025 after selling out during the quarter.
  • General Atlantic sold 3,782,339 Adagene shares in Q4 2025, an estimated $7.53M.
  • General Atlantic first reported a position in Adagene in Q1 2021 and held it in 19 quarters.
  • General Atlantic's Adagene position peaked at $7.61M in Q4 2024.
  • 17 funds tracked by Wall St. Rank held Adagene as of Q4 2025.

Based on General Atlantic's 13F filing for Q4 2025, filed 17 Feb 2026.